Louisiana State Employees Retirement System’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$850K Sell
101,600
-3,900
-4% -$35.6K 0.01% 1182
2026
Q1
$951K Sell
105,500
-3,500
-3% -$55.2K 0.02% 1062
2025
Q4
$1.99M Sell
109,000
-700
-0.6% -$11.8K 0.03% 540
2025
Q3
$1.61M Sell
109,700
-1,800
-2% -$30.9K 0.03% 691
2025
Q2
$2.03M Buy
111,500
+200
+0.2% +$4.08K 0.04% 499
2025
Q1
$2.21M Sell
111,300
-3,000
-3% -$51.9K 0.04% 425
2024
Q4
$1.96M Buy
114,300
+1,600
+1% +$30.1K 0.04% 524
2024
Q3
$2.25M Buy
+112,700
New +$1.75M 0.04% 442

Other funds holding ADMA

Louisiana State Employees Retirement System's ADMA Position: Q2 2026 in Review

Louisiana State Employees Retirement System reduced its ADMA Biologics (ADMA) stake by 3.7% in Q2 2026, selling an estimated $35.6K and leaving 101,600 shares worth $850K. The position accounts for 0.01% of the portfolio, ranked #1182.

Louisiana State Employees Retirement System first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.25M in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Louisiana State Employees Retirement System held 101,600 shares of ADMA Biologics worth $850K as of Q2 2026.
  • Louisiana State Employees Retirement System sold 3,900 ADMA Biologics shares in Q2 2026, an estimated $35.6K.
  • ADMA Biologics made up 0.01% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #1182 holding.
  • Louisiana State Employees Retirement System first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
  • Louisiana State Employees Retirement System's ADMA Biologics position peaked at $2.25M in Q3 2024.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.